Correlation Between Burning Rock and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Burning Rock and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Burning Rock and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Burning Rock Biotech and Champions Oncology, you can compare the effects of market volatilities on Burning Rock and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Burning Rock with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Burning Rock and Champions Oncology.

Diversification Opportunities for Burning Rock and Champions Oncology

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Burning and Champions is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Burning Rock Biotech and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Burning Rock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Burning Rock Biotech are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Burning Rock i.e., Burning Rock and Champions Oncology go up and down completely randomly.

Pair Corralation between Burning Rock and Champions Oncology

Considering the 90-day investment horizon Burning Rock Biotech is expected to under-perform the Champions Oncology. In addition to that, Burning Rock is 1.53 times more volatile than Champions Oncology. It trades about -0.04 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.0 per unit of volatility. If you would invest  538.00  in Champions Oncology on August 31, 2024 and sell it today you would lose (86.00) from holding Champions Oncology or give up 15.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Burning Rock Biotech  vs.  Champions Oncology

 Performance 
       Timeline  
Burning Rock Biotech 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Burning Rock Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Burning Rock reported solid returns over the last few months and may actually be approaching a breakup point.
Champions Oncology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Burning Rock and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Burning Rock and Champions Oncology

The main advantage of trading using opposite Burning Rock and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Burning Rock position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind Burning Rock Biotech and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume